Opioid rehab is treatment for heroin, fentanyl, oxycodone, hydrocodone, and other opioid use disorders. Programs may include medical detox, medication-assisted treatment (MAT), residential care, outpatient therapy, and relapse-prevention planning. Compare options by location and level of care.
Confidential · No cost to call · City & state directories available
Opioid rehab is clinical treatment for opioid use disorder (OUD) — a chronic condition involving dependence on heroin, fentanyl, oxycodone, hydrocodone, or other opioids. Treatment is not a single service. It typically spans multiple phases, beginning with stabilization and continuing through therapy, medication support, and long-term recovery planning.
The right starting point depends on the type of opioid being used, length of use, withdrawal history, prior overdoses, co-occurring mental health needs, home stability, and whether medication-assisted treatment has been used before. A clinical assessment helps determine where to begin.
Treatment needs vary by substance, route of use, and dependence severity. Use these categories to understand what to expect before contacting an opioid rehab program.
Illicit opioid — often injected, smoked, or snorted
High-potency synthetic — increasingly in illicit supply
Oxycodone, hydrocodone, codeine, morphine, tramadol
Opioids combined with benzodiazepines, stimulants, or alcohol
Overdose emergency: Call 911 immediately. If naloxone (Narcan) is available, administer it. Do not leave the person alone. Opioid overdose is a medical emergency — do not use this directory in a crisis situation.
Opioid withdrawal is rarely life-threatening, but it can be severely uncomfortable, and the risk of relapse and overdose during and after unmanaged withdrawal is significant. Medical detox provides monitoring, comfort medications, and clinical support while opioids leave the body.
Opioid withdrawal typically begins within hours of the last dose and may last several days. With fentanyl or long-acting opioids, withdrawal can be prolonged. Medication support during detox — including buprenorphine or clonidine — can significantly reduce discomfort and reduce dropout risk.
Opioid withdrawal timing varies by substance (short-acting vs. long-acting), dose, and individual biology. This is a general reference — clinical guidance supersedes any general timeline.
Anxiety, restlessness, yawning, watery eyes, runny nose, and early muscle aches begin. Short-acting opioids (heroin, oxycodone) onset faster than long-acting ones (methadone, buprenorphine).
Nausea, vomiting, diarrhea, severe muscle cramps, sweating, chills, elevated heart rate, and insomnia. This is typically when discomfort is most intense and dropout risk is highest.
Physical symptoms begin to ease for most short-acting opioids. Fentanyl and methadone withdrawal may peak later and last longer. Sleep disruption and cravings remain significant.
Post-acute withdrawal syndrome (PAWS) can include ongoing fatigue, mood changes, sleep issues, and cravings for weeks or months. MAT, therapy, and peer support reduce PAWS impact significantly.
MAT combines FDA-approved medications with counseling and behavioral therapy. It is the most evidence-supported approach to opioid use disorder and significantly reduces overdose risk, illicit opioid use, and treatment dropout.
Not all opioid rehab programs offer medication-assisted treatment on site. Some refer to external MAT providers. Ask directly: Is MAT available? Which medications? Is it integrated with therapy? Is MAT continued after discharge? Choosing a program that supports MAT rather than requiring abstinence-only approaches is a clinically meaningful decision for opioid use disorder.
Partial opioid agonist — prescribed by certified providers
Full opioid agonist — dispensed through licensed OTP clinics
Opioid antagonist — blocks opioid effects completely
Naloxone (Narcan) is a medication that rapidly reverses opioid overdose. It is available over the counter at many pharmacies in the US without a prescription and can be a critical harm-reduction tool while a person is in active use or early recovery.
Anyone in a household with a person using opioids — or in early recovery — should have naloxone on hand and know how to use it. A single dose may not be enough for fentanyl overdose; repeat doses or the 8mg nasal spray formulation may be needed.
Opioid use disorder treatment spans multiple levels. The right starting point depends on withdrawal risk, prior treatment history, home stability, and clinical assessment.
Supervised withdrawal management for opioid dependence. May include buprenorphine or clonidine to reduce symptoms. Detox alone is not treatment for OUD — ask what happens next and whether MAT is initiated during or after detox.
Live-in treatment with structured daily programming, therapy, peer support, and 24-hour clinical access. Often used when outpatient care has not been sufficient or when a stable, trigger-free environment is needed. Ask whether MAT is available within the residential program.
Partial hospitalization provides intensive daily treatment while the person lives off site. PHP is appropriate as a step down from residential care or as an entry point with a stable living situation. Ask about MAT integration and daily structure.
Intensive outpatient programs meet several days per week and support people maintaining home, school, or work responsibilities. Often combined with MAT prescriptions and individual therapy. Ask about the schedule, frequency, and whether MAT is part of the program.
Office-based buprenorphine treatment (OBOT) allows patients to receive MAT prescriptions in a standard outpatient clinical setting. Methadone requires a licensed OTP clinic. Ask about the frequency of visits, counseling requirements, and what support is available between appointments.
Many people with opioid use disorder also have anxiety, depression, PTSD, or trauma. Dual-diagnosis treatment addresses both conditions simultaneously. Ask how mental health care is integrated and whether psychiatric support and therapy are available within the program.
Opioid treatment is rarely a single event. A complete recovery plan typically spans several phases, from stabilization through ongoing support.
A clinical intake or admissions assessment evaluates withdrawal risk, substance use history, mental health needs, home stability, insurance, and care preferences. This determines the recommended level of care and whether MAT is appropriate.
Medical detox or MAT induction manages withdrawal and stabilizes the person physically. For opioid use disorder, this often means beginning buprenorphine or methadone to reduce cravings and prevent early dropout.
Residential, PHP, or IOP programs provide structured therapy, group counseling, relapse-prevention skills, and peer support. MAT is typically continued throughout this phase. Dual-diagnosis mental health care is addressed concurrently if needed.
Aftercare includes ongoing MAT, outpatient therapy, alumni support, sober living, SMART Recovery, Narcotics Anonymous, and relapse-prevention planning. Ask every opioid rehab program how they handle discharge and ongoing support.
MAT addresses the biological aspects of opioid use disorder. Therapy addresses behavioral patterns, triggers, trauma, and long-term recovery skills. Both together produce better outcomes than either alone.
Helps identify thought patterns and behaviors that contribute to opioid use. CBT builds coping skills, stress management strategies, and relapse-prevention techniques that carry into daily life after treatment.
Uses positive reinforcement (rewards) for negative drug tests and treatment attendance. One of the most evidence-supported behavioral approaches for opioid and stimulant use disorders. Ask whether any program incorporates it.
A patient-centered counseling approach that helps people explore their own reasons for change. Particularly useful in early treatment when ambivalence about recovery is common. Often used during intake and throughout early treatment phases.
Opioid use disorder affects entire families. Family therapy improves communication, establishes healthy boundaries, and helps loved ones understand addiction as a treatable medical condition. Ask whether family involvement is offered or encouraged in the program.
Many people with opioid use disorder have underlying trauma, PTSD, or adverse childhood experiences. Trauma-informed programs recognize this connection and integrate trauma treatment into opioid rehab rather than treating them separately.
People with lived experience of opioid use and recovery serving as recovery coaches or peer specialists. Particularly valuable in early recovery, during transitions between care levels, and in aftercare planning.
Many opioid rehab searches start with a parent, spouse, sibling, or close friend. It is common to feel scared, unsure about what to say, or uncertain whether the person will accept help.
Use this directory to understand opioid treatment options before starting the conversation. Knowing the difference between detox and residential care, and understanding what MAT is, can help you ask the right questions when you call an admissions team.
Common questions about opioid withdrawal, MAT medications, detox, residential treatment, and how to start the search for a program.
"Opioid use disorder is a chronic medical condition. MAT combined with therapy and recovery support is the most evidence-supported treatment approach available."
Opioid withdrawal is rarely directly life-threatening, but it is very uncomfortable, and the risk of relapse and fatal overdose during unmanaged withdrawal is significant — particularly because tolerance drops rapidly during withdrawal. Medical detox provides supervision, comfort medications, and MAT initiation to reduce this risk. Always seek medical guidance rather than attempting unsupervised withdrawal from heavy opioid use.
No, but MAT (medication-assisted treatment) is strongly supported by clinical evidence for opioid use disorder and significantly reduces overdose risk, illicit opioid use, and treatment dropout. Some programs require abstinence-only approaches. If you or a loved one wants to pursue MAT, choose a program that supports and offers it — this is a clinically important decision, not just a preference.
Both are used for opioid use disorder. Buprenorphine (Suboxone) is a partial opioid agonist that can be prescribed in outpatient office settings. Methadone is a full opioid agonist dispensed only through licensed OTP clinics with daily attendance required initially. Both are effective; the right choice depends on severity of dependence, prior treatment history, and access to each type of provider.
Opioid detox may last several days. Residential treatment typically ranges from 28–90 days depending on clinical need. PHP and IOP programs may continue for weeks or months. MAT is often continued long-term — ask any program about their philosophy on MAT duration, as stopping MAT prematurely significantly increases overdose risk. Recovery is long-term, not time-limited.
Yes. Medicaid covers opioid use disorder treatment — including MAT — in most US states under federal mental health parity rules. Many programs also offer sliding scale fees, state-funded treatment, or can help connect uninsured people with local resources. Always confirm insurance and payment options directly with the facility before admission.
Post-acute withdrawal syndrome (PAWS) refers to a cluster of symptoms — including fatigue, sleep disruption, mood changes, irritability, and cravings — that can persist for weeks or months after acute physical withdrawal ends. PAWS is common with opioid use disorder and is a significant relapse risk. MAT, ongoing therapy, and peer support reduce PAWS severity and its impact on early recovery.
Inpatient or residential care is typically recommended when outpatient treatment has not been sufficient, when the home environment is unsafe or trigger-heavy, when a co-occurring mental health condition requires more intensive support, or when prior treatment attempts have resulted in relapse. Outpatient care with MAT may be appropriate for people with stable housing, strong support, and lower severity of dependence.
Ask whether MAT is available and which medications are offered. Ask whether detox is on site and medically supervised. Ask how mental health conditions are addressed. Ask about aftercare planning and what happens after the first phase of treatment. Ask about insurance acceptance, cost, and availability. Ask whether family involvement or family therapy is offered.
No. This is an informational directory only. It does not diagnose conditions, recommend specific programs, or replace a clinical assessment. For overdose emergencies, call 911 immediately. For a clinical evaluation, contact a licensed healthcare provider or an opioid treatment program directly.
Browse related treatment pages, state directories, and levels of care specific to opioid use disorder.
Find medically supervised opioid detox programs in your state.
Browse Detox →Compare drug rehab options for opioids, stimulants, benzodiazepines, and polysubstance use.
Explore Drug Rehab →Treatment for opioid use disorder alongside anxiety, depression, PTSD, or trauma.
Explore Dual Diagnosis →Find opioid rehab centers in your state — detox, residential, PHP, IOP, and MAT.
Browse States →Browse opioid rehab centers by state or city, compare MAT programs, detox options, and residential care, and prepare your questions before calling an admissions team. Confidential and no cost to use.